glp-1 receptor agonists cardiovascular benefits The Biology of Glucagon-like Peptide-1 GLP-1 drugs improve liver and

Sports 35 , 318319 (2020)

Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer

GLP-1 receptor agonists: Dual systems of care in 2026 GLP-1 receptor agonists have undergone one of the most significant identity shifts in modern pharmacotherapy

The first draft of the manuscript was written by [Juliana Giorgi], improved by [Mrunalini Dandamudi], and reviewed by [Alejandro Barbagelata] and [Edgardo Kaplinsky]

[49] further noted that GLP1R is widely expressed in retinal endothelial cells, and its activation significantly inhibits the expression and secretion of multiple inflammatory factors such as TNF- and IL1, reducing immune cell infiltration